SCIASCIA THOMAS (Chief Medical Officer) sold 7.0% of their position (16.50K shares) of TREVI THERAPEUTICS, INC. on the open market
Open‑market sale worth $48.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/21/2024ACC: 0000950170-24-099481
Officer10% Owner· Chief Medical Officer
Since May 2019
-16.50K
Net shares
Net seller
$48.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
16.50K acquired · 32.99K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+16.50K
Price / share
$1.43
Trade value
$23.59K
% of position
7.5%
8/19/2024
220.31K→236.81K
Common Stock
Direct
Shares
−16.50K
Price / share
$2.96
Trade value
$48.88K
% of position
7.0%
8/19/2024
236.81K→220.31K
Total
Net shares
+0.00
Net value
-$25.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/19/2024 | M · Option Exercise | +16.50K | $1.43 | $23.59K | 7.5% | 220.31K | 236.81K |
| Common Stock Direct | 8/19/2024 | S · Sale | −16.50K | $2.96 | $48.88K | 7.0% | 236.81K | 220.31K |
| Total | +0.00 | -$25.29K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
16.50K shares
Shares
−16.50K
Strike price
1.43
Held after
0.00
Exercisable
—
8/19/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock16.50K shares | 8/19/2024 | M · Option Exercise | −16.50K | 1.43 | — | 0.00 |